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1. Introduction 
Recently, nonoperative treatment such as chemotherapy or radiotherapy has commonly 
been performed for submucosal carcinoma of the esophagus. Although endoscopic mucosal 
resection1)2) (EMR) or endoscopic submucosal dissection3) (ESD) is usually done as curative 
treatment for mucosal cancer of the esophagus, the efficacy of multimodal therapy 
combined with EMR/ESD for esophageal squamous cell carcinoma (SCC) with submucosal 
invasion is controversial. 
At our hospital, several patients who had SCC with submucosal invasion received multimodal 
therapy combined with EMR or ESD, and the results are reported here. 
2. Patients and methods 
From 1996 to 2005, 36 patients who had esophageal SCC with submucosal invasion 
underwent multimodal treatment. Esophagectomy was not performed because of associated 
complications in 19 cases and due to patient refusal in 17 cases. 
In all patients, EMR/ESD was performed before any other treatment. Then chemotherapy, 
radiotherapy, or chemoradiotherapy was added, depending on the histopathological 
findings, which were classified according to the Guidelines for Clinical and Pathologic 
Studies on Carcinoma of the Esophagus4). Submucosal invasion was classified into the 
following three grades: sm1: ≤200 μm, sm2: >200 μm, and sm2 EM (+): residual cancer cells 
at the resected margin. 
In principle, radiotherapy or chemoradiotherapy was added if the resected margin was 
suspected to contain residual cancer cells, while chemotherapy was performed if lymphatic 
invasion was found in the resected specimen (Fig 1). Argon plasma coagulation was added 
without radiation if the residual tumor was limited to a small area. 
2.1 Method of EMR 
EMR was performed by the EEMR or EMRC method1)2). EMRC was done by using a single-
channel endoscope (GIF Q260; Olympus) with a cap (Olympus, Tokyo, Japan). After 
chromoendoscopy with iodine solution, saline was injected into the submucosal layer. 
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Next, a snare (SD-7P, Olympus) was opened inside the cap, the tumor was aspirated into 
the cap, and the snare was closed. The forced coagulation mode was used to perform 
resection. EMMR was done by using a single-channel endoscope (GIF Q260; Olympus) 
fitted with an EEMR-tube. The method was same as that for EMRC until the injection of 
saline. Then a snare (SD-7P, Olympus) was passed through a side channel of the tube and 
was opened over the tumor. The tumor was aspirated into the tube using the suction of the 
endoscope and the snare was tightened. Resection was done in the forced coagulation 
mode. 
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Fig. 1. Fundamental clinical course 
2.2 Method of ESD 
A hook knife from Olympus (Tokyo, Japan) was used for the hook knife method of ESD3)5) 
along with a single-channel endoscope (GIF Q260; Olympus) and an attachment. The 
electrical generator was a VIO (ERBE, Tübingen, Germany). Before marking, 
chromoendoscopy with iodine solution was done to identify the lateral margins of the 
lesion. Then marking was undertaken in the hook knife using the forced coagulation mode. 
After 10% glycerin was injected into the submucosal, mucosal incision was performed in the 
endo cut mode. Before performing submucosal dissection, hyaluronic acid solution was 
injected into the submucosal lesion. Then the clip with thread was attached to the oral 
border of the specimen and the thread was pulled in the oral direction to exert traction on 
the submucosal layer. Next, the submucosal lesion was dissected off the muscle layer by 
using the hook knife in the endo cut mode. Bleeding was controlled with hemostatic forceps 
(FD-411QR; Olympus) in the soft coagulation mode or with the hook knife in the spray 
mode. ESD was performed with the patient under sedation by intravenous administration of 
diazepam and pentazocine as required plus continuous infusion of propofol. 
2.3 Chemotherapy and radiotherapy 
Chemotherapy was performed for 2 courses if lymphatic invasion was found in the resected 
specimen. Patients were principally given a combination of cisplatin/5-fluorouracil or 
nedaplatin/5-fluorouracil (Fig. 2). Radiotherapy was given to a total dose of 50-60 Gy, with 
the radiation field being limited to the local tumor area (Fig. 3). 
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Fig. 2. Chemotherapy and chemoradiotherapy 
 
 
Fig. 3. The radiation field was limited to local area 
3. Results 
There were no complications of EMR/ESD. On histopathological examination, the depth of 
tumor invasion was sm1 in 22 cases, sm2 in 9, and sm2 EM (+) in 5. Lymphatic invasion (ly) 
was found in 18 cases (50%), and there was 1 case (3%) of vascular invasion (v).  
Sixteen patients were treated with EMR alone, 8 received EMR + chemotherapy, 2 had EMR 
+ radiotherapy, and 10 had EMR + chemoradiotherapy. 
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Fig. 4. 0-IIa+IIc lesion was seen in middle esophagus. EMR was performed 
 
 
Mod.SCC,pSM1, ly3, v0, INFc→CRT(ND+5FU, 66Gy) 
Fig. 5. Though pathological finding showed moderate. SCC, pSM1, ly3, v0, chemoradiotherapy 
was treated 
Recurrence was diagnosed in three patients. Medistinal lymph node recurrence occurred in 
a man with moderately differentiated SCC (sm1, ly (-)) treated by EMR alone and cervical 
lymph node recurrence was detected in 1 woman with moderately differentiated SCC (sm2, 
ly (+)) treated by EMR alone. Both cervical lymph node recurrence and intramural 
metastasis were detected in 1 man with moderately differentiated SCC (sm1, ly (+)) treated 
by EMR + chemoradiotherapy (Fig. 4-6). Local recurrence did not occur.  
There was 1 death from the primary disease and 10 patients died of other diseases. The 
overall survival rate was 69% (Fig. 7). 
4. Discussion 
Curative surgery has been considered the standard treatment for squamous cell carcinoma 
of the esophagus with submucosal invasion (T1b) because of the possibility of lymph node 
metastasis6)7)8). Although chemoradiotherapy (CRT) has been performed recently for T1bN0 
cancer, it is controversial whether CRT has the same therapeutic effect as surgery, and a 
randomized controlled trial of surgery versus CRT is still ongoing.  
EMR has become widely employed for esophageal early carcinoma1)2) at a large number of 
institutions10). ESD has been adopted for the treatment of early esophageal cancer as a 
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Fig. 6. After 6 month later, intrmural metastasia and cervical lymph node were detected. The 
patient died from the primary disease 
method of excising extensive lesions en bloc. Endoscopic resection was previously considered 
to be curative for tumors limited to the proper mucosal layer9). Although the indications of 
EMR/ESD have been extended to tumors with invasion of the muscularis mucosae and 
submucosal tumors with a comparatively low rate of lymph node metastasis in recent 
years11)-13), these procedures are not indicated for tumors invading deeply into the 
submucosal layer.  
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Fig. 7.  Over all survival 
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One advantage of EMR/ESD is that histopathological examination is possible, which allows 
us to identify the patients who do not need chemotherapy or radiotherapy. EMR/ESD 
seemed to be effective because there was no local recurrence and residual tumor. There were 
many high risk patients in our series, so deaths from other causes were frequent. Thus, a 
randomized controlled trial will be needed to evaluate the correct survival rate. There were 
also cases of cervical and mediastinal lymph node recurrence in our series. These lymph 
nodes are removed by esophagectomy with 3-field dissection, so recurrences would have 
been avoided if esophagectomy had been performed in such patients. Accordingly, 
EMR/ESD needs to be selected carefully. 
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